Pentixapharm Holding AG (FRA:PTP)

Germany flag Germany · Delayed Price · Currency is EUR
2.975
+0.080 (2.76%)
Last updated: May 13, 2025
-41.67%
Market Cap 73.73M
Revenue (ttm) 306.00K
Net Income (ttm) -16.86M
Shares Out n/a
EPS (ttm) -0.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,594
Average Volume 24,267
Open 2.885
Previous Close 2.895
Day's Range 2.870 - 2.975
52-Week Range 2.375 - 5.150
Beta n/a
RSI 50.24
Earnings Date May 8, 2025

About Pentixapharm Holding AG

Pentixapharm Holding AG operates as a clinical-stage radiopharmaceutical development company. It focuses on developing CXCR4 ligand-based radiopharmaceutical approaches for diagnostic and therapeutic programs in various hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company’s clinical pipeline includes PentixaTher, an Yttrium-90-based therapeutic against non-Hodgkin lymphomas; and PentixaFor, a Gallium-68-based companion diagnostic. Its clinical studies for compounds have commenced in Europ... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2019
Employees 75
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol PTP
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.